On the public citation graph

De Novo Design of Bioactive Small Molecules by Artificial Intelligence

0 signed · 382 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/minf.201700030openalex-snapshot
Finding Chemical Structures Corresponding to a Set of Coordinates in Chemical Descriptor Space
inferredcites →https://doi.org/10.1002/minf.201700111openalex-snapshot
Generative Recurrent Networks for De Novo Drug Design
inferredcites →https://doi.org/10.1002/minf.201700123openalex-snapshot
Application of Generative Autoencoder in De Novo Molecular Design
inferredcites →https://doi.org/10.1002/minf.201700153openalex-snapshot
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
inferredcites →https://doi.org/10.1007/978-1-60761-839-3_12openalex-snapshot
De Novo Drug Design
inferredcites →https://doi.org/10.1016/s0960-894x(01)00188-3openalex-snapshot
Identification of a subtype selective human PPARα agonist through parallel-array synthesis
inferredcites →https://doi.org/10.1021/acs.jmedchem.5b01849openalex-snapshot
De Novo Design at the Edge of Chaos
inferredcites →https://doi.org/10.1021/acs.jmedchem.6b01287openalex-snapshot
Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery
inferredcites →https://doi.org/10.1021/acs.jmedchem.7b00398openalex-snapshot
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1021/jm00044a014openalex-snapshot
Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective Retinoids
inferredcites →https://doi.org/10.1021/jm990554gopenalex-snapshot
The PPARs: From Orphan Receptors to Drug Discovery
inferredcites →https://doi.org/10.1038/nrd1799openalex-snapshot
Computer-based de novo design of drug-like molecules
inferredcites →https://doi.org/10.1073/pnas.1320001111openalex-snapshot
Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus
inferredcites →https://doi.org/10.1093/nar/gkt1031openalex-snapshot
The ChEMBL bioactivity database: an update
inferredcites →https://doi.org/10.1093/nar/gkv1253openalex-snapshot
SureChEMBL: a large-scale, chemically annotated patent document database
inferredcites →https://doi.org/10.1093/nar/gkv951openalex-snapshot
PubChem Substance and Compound databases
inferredcites →https://doi.org/10.1124/pr.58.4.5openalex-snapshot
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
inferredcites →https://doi.org/10.1124/pr.58.4.7openalex-snapshot
International Union of Pharmacology. LXIII. Retinoid X Receptors
inferredcites →https://doi.org/10.1162/neco.1997.9.8.1735openalex-snapshot
Long Short-Term Memory
inferredcites →https://doi.org/10.1186/s13321-017-0235-xopenalex-snapshot
Molecular de-novo design through deep reinforcement learning

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/0471266949.bmc122.pub2openalex-snapshot
Advances in Multiobjective Optimization for Drug Discovery and Development
inferred← citeshttps://doi.org/10.1002/9781119857983.ch1openalex-snapshot
Deep Learning and Site‐Specific Drug Delivery
inferred← citeshttps://doi.org/10.1002/9781119865728.ch1openalex-snapshot
Introduction to Bioinformatics, AI, and ML for Pharmaceuticals
inferred← citeshttps://doi.org/10.1002/9781394234196.ch7openalex-snapshot
Revolutionizing Drug Discovery
inferred← citeshttps://doi.org/10.1002/9781394371112.ch11openalex-snapshot
De Novo Drug Design: From Fragment‐based to AI ‐driven Approaches
inferred← citeshttps://doi.org/10.1002/9783527840748.ch21openalex-snapshot
Advances in the Application of In Silico ADMET Models – An Industry Perspective
inferred← citeshttps://doi.org/10.1002/ange.201814681openalex-snapshot
Automated De Novo Drug Design: Are We Nearly There Yet?
inferred← citeshttps://doi.org/10.1002/ange.201909987openalex-snapshot
Autonome Entdeckung in den chemischen Wissenschaften, Teil I: Fortschritt
inferred← citeshttps://doi.org/10.1002/ange.201909989openalex-snapshot
Autonome Entdeckung in den chemischen Wissenschaften, Teil II: Ausblick
inferred← citeshttps://doi.org/10.1002/ange.202104405openalex-snapshot
Beam‐Search zum automatisierten Entwurf und Scoring neuer ROR‐Liganden mithilfe maschineller Intelligenz**
inferred← citeshttps://doi.org/10.1002/anie.201814681openalex-snapshot
Automated De Novo Drug Design: Are We Nearly There Yet?
inferred← citeshttps://doi.org/10.1002/anie.201909987openalex-snapshot
Autonomous Discovery in the Chemical Sciences Part I: Progress
inferred← citeshttps://doi.org/10.1002/anie.201909989openalex-snapshot
Autonomous Discovery in the Chemical Sciences Part II: Outlook
inferred← citeshttps://doi.org/10.1002/anie.202104405openalex-snapshot
Beam Search for Automated Design and Scoring of Novel ROR Ligands with Machine Intelligence**
inferred← citeshttps://doi.org/10.1002/cbic.202200776openalex-snapshot
Structure‐Based Drug Discovery with Deep Learning**
inferred← citeshttps://doi.org/10.1002/cbic.202300816openalex-snapshot
The Role of AI in Drug Discovery
inferred← citeshttps://doi.org/10.1002/cmdc.201800204openalex-snapshot
Designing Anticancer Peptides by Constructive Machine Learning
inferred← citeshttps://doi.org/10.1002/cmdc.202000786openalex-snapshot
Design and Synthesis of DDR1 Inhibitors with a Desired Pharmacophore Using Deep Generative Models
inferred← citeshttps://doi.org/10.1002/ddr.70229openalex-snapshot
Artificial Intelligence in Drug Discovery: Integrative Advances From Data to Therapeutic Innovation
inferred← citeshttps://doi.org/10.1002/minf.201900126openalex-snapshot
Effect of Structural Descriptors on the Design of Cyclin Dependent Kinase Inhibitors Using Similarity‐based Molecular Evolution
inferred← citeshttps://doi.org/10.1002/minf.202000109openalex-snapshot
Virtual Screening and Design with Machine Intelligence Applied to Pim‐1 Kinase Inhibitors
inferred← citeshttps://doi.org/10.1002/minf.70000openalex-snapshot
Rapid Assessment of Virtually Synthesizable Chemical Structures via Support Vector Machine Models
inferred← citeshttps://doi.org/10.1002/minf.70005openalex-snapshot
Integrating Generative Pretrained Transformer and Genetic Algorithms for Efficient and Diverse Molecular Generation
inferred← citeshttps://doi.org/10.1002/open.201900222openalex-snapshot
Synthetic Activators of Cell Migration Designed by Constructive Machine Learning
inferred← citeshttps://doi.org/10.1002/prep.70237openalex-snapshot
Rapid Generative Discovery of High‐Energy Molecules in Low Data Regimes Using Minimal Computational Resources
inferred← citeshttps://doi.org/10.1002/wcms.1395openalex-snapshot
Advances and challenges in deep generative models for de novo molecule generation
inferred← citeshttps://doi.org/10.1007/978-1-0716-0826-5_6openalex-snapshot
Computational Approaches for De Novo Drug Design: Past, Present, and Future
inferred← citeshttps://doi.org/10.1007/978-1-0716-1209-5_2openalex-snapshot
Molecular Scaffold Hopping via Holistic Molecular Representation
inferred← citeshttps://doi.org/10.1007/978-1-0716-1767-0_9openalex-snapshot
Computational Methods for Structure-Based Drug Design Through System Biology
inferred← citeshttps://doi.org/10.1007/978-1-0716-1787-8_12openalex-snapshot
Deep Learning Applied to Ligand-Based De Novo Drug Design
inferred← citeshttps://doi.org/10.1007/978-1-0716-1787-8_15openalex-snapshot
Artificial Intelligence in Compound Design
inferred← citeshttps://doi.org/10.1007/978-1-0716-1787-8_16openalex-snapshot
Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases
inferred← citeshttps://doi.org/10.1007/978-1-0716-1787-8_6openalex-snapshot
Has Artificial Intelligence Impacted Drug Discovery?
inferred← citeshttps://doi.org/10.1007/978-1-0716-1787-8_9openalex-snapshot
De Novo Molecular Design with Chemical Language Models
inferred← citeshttps://doi.org/10.1007/978-1-0716-2728-0_39openalex-snapshot
Machine Learning and Computational Chemistry for the Endocannabinoid System
inferred← citeshttps://doi.org/10.1007/978-3-030-14632-0_3openalex-snapshot
A Toolbox for the Identification of Modes of Action of Natural Products
inferred← citeshttps://doi.org/10.1007/978-3-030-72588-4_10openalex-snapshot
Artificial Intelligence for Healthcare: Roles, Challenges, and Applications
inferred← citeshttps://doi.org/10.1007/978-3-662-66285-4_4openalex-snapshot
Künstliche Intelligenz
inferred← citeshttps://doi.org/10.1007/978-981-16-0811-7_1openalex-snapshot
Practical Applications of Artificial Intelligence for Disease Prognosis and Management
inferred← citeshttps://doi.org/10.1007/978-981-95-2525-6_1openalex-snapshot
Introduction: The Development of Artificial Intelligence and Drug Design
inferred← citeshttps://doi.org/10.1007/978-981-97-3705-5_6openalex-snapshot
Explainable Artificial Intelligence in Drug Discovery
inferred← citeshttps://doi.org/10.1007/978-981-99-4749-2_54openalex-snapshot
De Novo Drug Design Using Unified Multilayer Simple Recurrent Unit Model
inferred← citeshttps://doi.org/10.1007/s00191-023-00845-3openalex-snapshot
Superhuman science: How artificial intelligence may impact innovation
inferred← citeshttps://doi.org/10.1007/s00894-019-4007-6openalex-snapshot
De novo design of anticancer peptides by ensemble artificial neural networks
inferred← citeshttps://doi.org/10.1007/s00894-021-04674-8openalex-snapshot
Generative chemistry: drug discovery with deep learning generative models
inferred← citeshttps://doi.org/10.1007/s10822-022-00493-yopenalex-snapshot
DeepCubist: Molecular Generator for Designing Peptidomimetics based on Complex three-dimensional scaffolds
inferred← citeshttps://doi.org/10.1007/s10822-026-00946-8openalex-snapshot
Chemical language models for early-stage drug discovery: applications, pitfalls, and future directions
inferred← citeshttps://doi.org/10.1007/s11030-021-10217-3openalex-snapshot
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
inferred← citeshttps://doi.org/10.1007/s12013-025-01983-0openalex-snapshot
Unveiling the Influence of Polyphenols on Mitogen-activated Protein Kinases in Cancer
inferred← citeshttps://doi.org/10.1007/s40199-024-00548-5openalex-snapshot
Advances in artificial intelligence-based technologies for increasing the quality of medical products
inferred← citeshttps://doi.org/10.1007/s42250-025-01343-8openalex-snapshot
Artificial Intelligence in Computational and Materials Chemistry: Prospects and Limitations
inferred← citeshttps://doi.org/10.1007/s43440-022-00445-1openalex-snapshot
Opportunities and challenges in application of artificial intelligence in pharmacology
inferred← citeshttps://doi.org/10.1007/s44163-025-00330-9openalex-snapshot
Unraveling the artificial intelligence role in drug discovery and pharmaceutical product design: an opportunity and challenges
inferred← citeshttps://doi.org/10.1007/s44230-023-00038-yopenalex-snapshot
Survey on Explainable AI: From Approaches, Limitations and Applications Aspects
inferred← citeshttps://doi.org/10.1007/s44371-026-00516-9openalex-snapshot
Deep learning driven de novo smiles generation and in silico validation of potential therapeutics for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s44395-025-00008-2openalex-snapshot
Advancing drug discovery: the role of computer-aided design and development in modern pharmaceuticals
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.14703-1openalex-snapshot
Chemometrics for QSAR Modeling
inferred← citeshttps://doi.org/10.1016/b978-0-12-815585-1.00028-0openalex-snapshot
Artificial Intelligence: Emerging Applications in Biotechnology and Pharma
inferred← citeshttps://doi.org/10.1016/b978-0-12-818438-7.00002-2openalex-snapshot
The rise of artificial intelligence in healthcare applications
inferred← citeshttps://doi.org/10.1016/b978-0-12-820472-6.00041-4openalex-snapshot
The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery
inferred← citeshttps://doi.org/10.1016/b978-0-323-89824-9.00010-0openalex-snapshot
Translational bioinformatics methods for drug discovery and drug repurposing
inferred← citeshttps://doi.org/10.1016/b978-0-443-18638-7.00022-0openalex-snapshot
Chemical space and molecular descriptors for QSAR studies
inferred← citeshttps://doi.org/10.1016/b978-0-443-18638-7.00030-xopenalex-snapshot
Deep learning methodologies in drug design
inferred← citeshttps://doi.org/10.1016/b978-0-443-19073-5.00012-4openalex-snapshot
Medical applications of artificial intelligence
inferred← citeshttps://doi.org/10.1016/b978-0-443-24788-0.00007-8openalex-snapshot
Healthcare revolution: Advances in AI-driven medical imaging and diagnosis
inferred← citeshttps://doi.org/10.1016/b978-0-443-45105-8.00012-3openalex-snapshot
Introduction to computer-aided drug design
inferred← citeshttps://doi.org/10.1016/j.aichem.2023.100011openalex-snapshot
Application of artificial intelligence and machine learning in early detection of adverse drug reactions (ADRs) and drug-induced toxicity
inferred← citeshttps://doi.org/10.1016/j.aichem.2024.100049openalex-snapshot
Machine learning advancements in organic synthesis: A focused exploration of artificial intelligence applications in chemistry
inferred← citeshttps://doi.org/10.1016/j.aichem.2024.100075openalex-snapshot
Top 20 influential AI-based technologies in chemistry
inferred← citeshttps://doi.org/10.1016/j.ailsci.2023.100064openalex-snapshot
Exploring chemical space — Generative models and their evaluation
inferred← citeshttps://doi.org/10.1016/j.ailsci.2026.100159openalex-snapshot
Long short-term memory-based chemical language models for bioactive molecular generation using tailored pre-training datasets
inferred← citeshttps://doi.org/10.1016/j.biortech.2022.128523openalex-snapshot
Review on machine learning-based bioprocess optimization, monitoring, and control systems
inferred← citeshttps://doi.org/10.1016/j.bmcl.2018.06.046openalex-snapshot
Recent applications of machine learning in medicinal chemistry
inferred← citeshttps://doi.org/10.1016/j.celrep.2025.115836openalex-snapshot
Discovery of peptides as key regulators of metabolic and cardiovascular crosstalk
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2022.105403openalex-snapshot
Generative machine learning for de novo drug discovery: A systematic review
inferred← citeshttps://doi.org/10.1016/j.csbj.2022.07.049openalex-snapshot
On modeling and utilizing chemical compound information with deep learning technologies: A task-oriented approach
inferred← citeshttps://doi.org/10.1016/j.ddtec.2020.09.003openalex-snapshot
On failure modes in molecule generation and optimization
inferred← citeshttps://doi.org/10.1016/j.drudis.2018.03.011openalex-snapshot
Can we accelerate medicinal chemistry by augmenting the chemist with Big Data and artificial intelligence?
inferred← citeshttps://doi.org/10.1016/j.drudis.2018.11.014openalex-snapshot
Artificial intelligence in drug development: present status and future prospects
inferred← citeshttps://doi.org/10.1016/j.drudis.2019.07.006openalex-snapshot
Deep learning in drug discovery: opportunities, challenges and future prospects
inferred← citeshttps://doi.org/10.1016/j.drudis.2020.01.020openalex-snapshot
Exploring chemical space using natural language processing methodologies for drug discovery
inferred← citeshttps://doi.org/10.1016/j.drudis.2020.07.005openalex-snapshot
Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling
inferred← citeshttps://doi.org/10.1016/j.drudis.2020.10.010openalex-snapshot
Artificial intelligence in drug discovery and development
inferred← citeshttps://doi.org/10.1016/j.drudis.2021.11.023openalex-snapshot
Enhancing preclinical drug discovery with artificial intelligence
inferred← citeshttps://doi.org/10.1016/j.drudis.2024.103992openalex-snapshot
Unleashing the power of generative AI in drug discovery
inferred← citeshttps://doi.org/10.1016/j.drudis.2024.104133openalex-snapshot
Navigating the frontier of drug-like chemical space with cutting-edge generative AI models
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.112572openalex-snapshot
Automated design and optimization of multitarget schizophrenia drug candidates by deep learning
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.117164openalex-snapshot
Advanced AI and ML frameworks for transforming drug discovery and optimization: With innovative insights in polypharmacology, drug repurposing, combination therapy and nanomedicine
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117269openalex-snapshot
Progress of machine learning in the application of small molecule druggability prediction
inferred← citeshttps://doi.org/10.1016/j.ejmp.2021.03.026openalex-snapshot
Basic of machine learning and deep learning in imaging for medical physicists
inferred← citeshttps://doi.org/10.1016/j.geoen.2025.214010openalex-snapshot
Particle swarm optimization-based PINN for direct-simulation of fluids flow in subsurface reservoir
inferred← citeshttps://doi.org/10.1016/j.gresc.2021.11.007openalex-snapshot
The roles of computer-aided drug synthesis in drug development
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e40345openalex-snapshot
Computational design of CDK1 inhibitors with enhanced target affinity and drug-likeness using deep-learning framework
inferred← citeshttps://doi.org/10.1016/j.jhip.2024.12.002openalex-snapshot
Visual analysis of drug research and development based on artificial intelligence
inferred← citeshttps://doi.org/10.1016/j.jmb.2026.169985openalex-snapshot
The Allosteric Revolution: From Static Structures to Conformational Ensembles and Next-Generation Therapeutics
inferred← citeshttps://doi.org/10.1016/j.mencom.2021.11.003openalex-snapshot
Machine learning modelling of chemical reaction characteristics: yesterday, today, tomorrow
inferred← citeshttps://doi.org/10.1016/j.nxmate.2026.102883openalex-snapshot
Autonomous laboratories for sustainable nanomaterials discovery
inferred← citeshttps://doi.org/10.1016/j.phymed.2022.154324openalex-snapshot
A review on computational approaches that support the researches on traditional Chinese medicines (TCM) against COVID-19
inferred← citeshttps://doi.org/10.1016/j.sbi.2023.102527openalex-snapshot
Chemical language models for de novo drug design: Challenges and opportunities
inferred← citeshttps://doi.org/10.1016/j.sbi.2023.102548openalex-snapshot
Structure-based drug design with geometric deep learning
inferred← citeshttps://doi.org/10.1016/j.sbi.2023.102575openalex-snapshot
Artificial intelligence in molecular de novo design: Integration with experiment
inferred← citeshttps://doi.org/10.1016/j.sbi.2023.102658openalex-snapshot
Fake it until you make it? Generative de novo design and virtual screening of synthesizable molecules
inferred← citeshttps://doi.org/10.1016/j.sbi.2023.102746openalex-snapshot
Bonds and bytes: The odyssey of structural biology
inferred← citeshttps://doi.org/10.1016/j.tips.2019.09.004openalex-snapshot
Has Drug Design Augmented by Artificial Intelligence Become a Reality?
inferred← citeshttps://doi.org/10.1016/j.tips.2020.12.004openalex-snapshot
Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation
inferred← citeshttps://doi.org/10.1016/j.tips.2022.08.008openalex-snapshot
Targeting SARS-CoV-2 papain-like protease in the postvaccine era
inferred← citeshttps://doi.org/10.1016/j.ymeth.2020.06.016openalex-snapshot
Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition
inferred← citeshttps://doi.org/10.1021/acs.accounts.0c00699openalex-snapshot
Applications of Deep Learning in Molecule Generation and Molecular Property Prediction
inferred← citeshttps://doi.org/10.1021/acs.analchem.9b02348openalex-snapshot
Deep Learning to Generate in Silico Chemical Property Libraries and Candidate Molecules for Small Molecule Identification in Complex Samples
inferred← citeshttps://doi.org/10.1021/acs.chemmater.2c01860openalex-snapshot
Assessing Deep Generative Models in Chemical Composition Space
inferred← citeshttps://doi.org/10.1021/acs.chemrev.0c00901openalex-snapshot
Quantum Chemistry Calculations for Metabolomics
inferred← citeshttps://doi.org/10.1021/acs.chemrev.1c00107openalex-snapshot
Combining Machine Learning and Computational Chemistry for Predictive Insights Into Chemical Systems
inferred← citeshttps://doi.org/10.1021/acs.chemrev.5c00689openalex-snapshot
Molecular Design with Artificial Intelligence: Progress and Perspectives for Small Molecules
inferred← citeshttps://doi.org/10.1021/acs.jafc.3c06895openalex-snapshot
Discovery of Potential Neonicotinoid Insecticides by an Artificial Intelligence Generative Model and Structure-Based Virtual Screening
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c00120openalex-snapshot
Combining Cloud-Based Free-Energy Calculations, Synthetically Aware Enumerations, and Goal-Directed Generative Machine Learning for Rapid Large-Scale Chemical Exploration and Optimization
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c00517openalex-snapshot
De Novo Drug Design of Targeted Chemical Libraries Based on Artificial Intelligence and Pair-Based Multiobjective Optimization
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c00915openalex-snapshot
REINVENT 2.0: An AI Tool for De Novo Drug Design
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c01015openalex-snapshot
Scaffold-Constrained Molecular Generation
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c01344openalex-snapshot
Coloring Molecules with Explainable Artificial Intelligence for Preclinical Relevance Assessment
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c01496openalex-snapshot
Generative Deep Learning for Targeted Compound Design
inferred← citeshttps://doi.org/10.1021/acs.jcim.1c00746openalex-snapshot
Navigating Chemical Space by Interfacing Generative Artificial Intelligence and Molecular Docking
inferred← citeshttps://doi.org/10.1021/acs.jcim.1c01535openalex-snapshot
On the Value of Using 3D Shape and Electrostatic Similarities in Deep Generative Methods
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c00068openalex-snapshot
Effective Reaction-Based De Novo Strategy for Kinase Targets: A Case Study on MERTK Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c00079openalex-snapshot
Perplexity-Based Molecule Ranking and Bias Estimation of Chemical Language Models
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c00205openalex-snapshot
DeLA-Drug: A Deep Learning Algorithm for Automated Design of Druglike Analogues
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c00224openalex-snapshot
Exploration of Ultralarge Compound Collections for Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c00838openalex-snapshot
De Novo Drug Design Using Reinforcement Learning with Graph-Based Deep Generative Models
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c01073openalex-snapshot
Exposing the Limitations of Molecular Machine Learning with Activity Cliffs
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c01191openalex-snapshot
Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
inferred← citeshttps://doi.org/10.1021/acs.jcim.2c01345openalex-snapshot
Exploration of Chemical Space Guided by PixelCNN for Fragment-Based De Novo Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jcim.3c00579openalex-snapshot
Molecular Generation with Reduced Labeling through Constraint Architecture
inferred← citeshttps://doi.org/10.1021/acs.jcim.3c00651openalex-snapshot
De Novo Design of κ-Opioid Receptor Antagonists Using a Generative Deep-Learning Framework
inferred← citeshttps://doi.org/10.1021/acs.jcim.3c01031openalex-snapshot
Descriptor-Driven de Novo Design Algorithms for DOCK6 Using RDKit
inferred← citeshttps://doi.org/10.1021/acs.jcim.3c01456openalex-snapshot
ChemSpaceAL: An Efficient Active Learning Methodology Applied to Protein-Specific Molecular Generation
inferred← citeshttps://doi.org/10.1021/acs.jcim.3c01745openalex-snapshot
MARS Plus: An Improved Molecular Design Tool for Complex Compounds Involving Ionic, Stereo, and Cis–Trans Isomeric Structures
inferred← citeshttps://doi.org/10.1021/acs.jcim.4c00457openalex-snapshot
QSARtuna: An Automated QSAR Modeling Platform for Molecular Property Prediction in Drug Design
inferred← citeshttps://doi.org/10.1021/acs.jcim.4c01214openalex-snapshot
Navigating Ultralarge Virtual Chemical Spaces with Product-of-Experts Chemical Language Models
inferred← citeshttps://doi.org/10.1021/acs.jcim.5c00088openalex-snapshot
De Novo Design of Cyclic Peptide Binders Based on Fragment Docking and Assembling
inferred← citeshttps://doi.org/10.1021/acs.jcim.5c00641openalex-snapshot
Generative Deep Learning for de Novo Drug Design─A Chemical Space Odyssey
inferred← citeshttps://doi.org/10.1021/acs.jcim.5c00921openalex-snapshot
AI-Designed Molecules in Drug Discovery, Structural Novelty Evaluation, and Implications
inferred← citeshttps://doi.org/10.1021/acs.jcim.5c01915openalex-snapshot
MAPCliff-WMGR: Exploring Activity Cliffs in Molecular Activity Prediction Enhanced by Weighted Molecular Graph Representations
inferred← citeshttps://doi.org/10.1021/acs.jcim.8b00626openalex-snapshot
De Novo Molecule Design by Translating from Reduced Graphs to SMILES
inferred← citeshttps://doi.org/10.1021/acs.jcim.8b00794openalex-snapshot
Machine Learning Consensus To Predict the Binding to the Androgen Receptor within the CoMPARA Project
inferred← citeshttps://doi.org/10.1021/acs.jcim.8b00839openalex-snapshot
GuacaMol: Benchmarking Models for de Novo Molecular Design
inferred← citeshttps://doi.org/10.1021/acs.jcim.8b00902openalex-snapshot
Drug Analogs from Fragment-Based Long Short-Term Memory Generative Neural Networks
inferred← citeshttps://doi.org/10.1021/acs.jcim.9b00938openalex-snapshot
FragPELE: Dynamic Ligand Growing within a Binding Site. A Novel Tool for Hit-To-Lead Drug Design
inferred← citeshttps://doi.org/10.1021/acs.jcim.9b00943openalex-snapshot
Bidirectional Molecule Generation with Recurrent Neural Networks
inferred← citeshttps://doi.org/10.1021/acs.jcim.9b01075openalex-snapshot
Ranking Molecules with Vanishing Kernels and a Single Parameter: Active Applicability DomainIncluded
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00385openalex-snapshot
Learning Molecular Representations for Medicinal Chemistry
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00927openalex-snapshot
Generative Models for De Novo Drug Design
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c02042openalex-snapshot
Can Generative-Model-Based Drug Design Become a New Normal in Drug Discovery?
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00334openalex-snapshot
Defining Levels of Automated Chemical Design
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00732openalex-snapshot
RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c01179openalex-snapshot
ChemistGA: A Chemical Synthesizable Accessible Molecular Generation Algorithm for Real-World Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c00485openalex-snapshot
De Novo Design of Nurr1 Agonists via Fragment-Augmented Generative Deep Learning in Low-Data Regime
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c00627openalex-snapshot
PepScaf: Harnessing Machine Learning with In Vitro Selection toward De Novo Macrocyclic Peptides against IL-17C/IL-17RE Interaction
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c01551openalex-snapshot
Scaffold Fusion and SAR Transfer with a Chemical Language Model Generates Novel Liver X Receptor Modulators
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b00760openalex-snapshot
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b01048openalex-snapshot
Virtual Chemical Libraries
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b02044openalex-snapshot
Automated De Novo Design in Medicinal Chemistry: Which Types of Chemistry Does a Generative Neural Network Learn?
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b02147openalex-snapshot
Transfer Learning for Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.9b00500openalex-snapshot
Deep Convolutional Generative Adversarial Network (dcGAN) Models for Screening and Design of Small Molecules Targeting Cannabinoid Receptors
inferred← citeshttps://doi.org/10.1021/acsami.9b01226openalex-snapshot
Autonomous Molecular Design: Then and Now
inferred← citeshttps://doi.org/10.1021/acscatal.5c07050openalex-snapshot
Efficient Machine Learning for Yield Prediction in Transition Metal-Catalyzed meta -C(sp 2 )–H Bond Activation and Other Reactions
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.0c00088openalex-snapshot
The Advent of Generative Chemistry
inferred← citeshttps://doi.org/10.1021/acsomega.2c03264openalex-snapshot
A Generative Approach to Materials Discovery, Design, and Optimization
inferred← citeshttps://doi.org/10.1021/jacs.2c13467openalex-snapshot
Generative Models as an Emerging Paradigm in the Chemical Sciences
inferred← citeshttps://doi.org/10.1021/jacs.5c19960openalex-snapshot
Modular Framework for 3D Molecular Generation in Computational Chemistry Applications
inferred← citeshttps://doi.org/10.1021/jacsau.5c00602openalex-snapshot
Generative Deep Learning Pipeline Yields Potent Gram-Negative Antibiotics
inferred← citeshttps://doi.org/10.1038/s41467-019-13807-wopenalex-snapshot
De novo generation of hit-like molecules from gene expression signatures using artificial intelligence
inferred← citeshttps://doi.org/10.1038/s41467-022-30839-xopenalex-snapshot
Language models can learn complex molecular distributions
inferred← citeshttps://doi.org/10.1038/s41467-022-35692-6openalex-snapshot
Leveraging molecular structure and bioactivity with chemical language models for de novo drug design
inferred← citeshttps://doi.org/10.1038/s41467-024-47613-wopenalex-snapshot
Prospective de novo drug design with deep interactome learning
inferred← citeshttps://doi.org/10.1038/s41467-024-50469-9openalex-snapshot
Chemical language modeling with structured state space sequence models
inferred← citeshttps://doi.org/10.1038/s41467-024-52060-8openalex-snapshot
Automated design of multi-target ligands by generative deep learning
inferred← citeshttps://doi.org/10.1038/s41467-024-55072-6openalex-snapshot
Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery
inferred← citeshttps://doi.org/10.1038/s41467-026-71591-wopenalex-snapshot
Structural optimization of drug molecules with incrementally trained language models
inferred← citeshttps://doi.org/10.1038/s41557-019-0234-9openalex-snapshot
Computational advances in combating colloidal aggregation in drug discovery
inferred← citeshttps://doi.org/10.1038/s41573-019-0050-3openalex-snapshot
Rethinking drug design in the artificial intelligence era
inferred← citeshttps://doi.org/10.1038/s41587-019-0224-xopenalex-snapshot
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
inferred← citeshttps://doi.org/10.1038/s41587-020-0418-2openalex-snapshot
Assessing the impact of generative AI on medicinal chemistry
inferred← citeshttps://doi.org/10.1038/s41589-024-01679-1openalex-snapshot
Machine learning in preclinical drug discovery
inferred← citeshttps://doi.org/10.1038/s41598-018-34677-0openalex-snapshot
Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation
inferred← citeshttps://doi.org/10.1038/s41598-019-47148-xopenalex-snapshot
Optimization of Molecules via Deep Reinforcement Learning
inferred← citeshttps://doi.org/10.1038/s41598-020-78537-2openalex-snapshot
Autonomous molecule generation using reinforcement learning and docking to develop potential novel inhibitors
inferred← citeshttps://doi.org/10.1038/s41598-020-79682-4openalex-snapshot
Transformer neural network for protein-specific de novo drug generation as a machine translation problem
inferred← citeshttps://doi.org/10.1038/s41598-024-61124-0openalex-snapshot
Emerging opportunities of using large language models for translation between drug molecules and indications
inferred← citeshttps://doi.org/10.1038/s41598-024-66897-yopenalex-snapshot
Predicting blood–brain barrier permeability of molecules with a large language model and machine learning
inferred← citeshttps://doi.org/10.1038/s42004-018-0068-1openalex-snapshot
Tuning artificial intelligence on the de novo design of natural-product-inspired retinoid X receptor modulators
inferred← citeshttps://doi.org/10.1038/s42004-025-01423-3openalex-snapshot
fragSMILES as a chemical string notation for advanced fragment and chirality representation
inferred← citeshttps://doi.org/10.1038/s42004-025-01635-7openalex-snapshot
Optimizing drug design by merging generative AI with a physics-based active learning framework
inferred← citeshttps://doi.org/10.1038/s42256-019-0030-7openalex-snapshot
Mind and machine in drug design
inferred← citeshttps://doi.org/10.1038/s42256-019-0067-7openalex-snapshot
Automated de novo molecular design by hybrid machine intelligence and rule-driven chemical synthesis
inferred← citeshttps://doi.org/10.1038/s42256-020-00236-4openalex-snapshot
Drug discovery with explainable artificial intelligence
inferred← citeshttps://doi.org/10.1038/s42256-020-0160-yopenalex-snapshot
Generative molecular design in low data regimes
inferred← citeshttps://doi.org/10.1038/s42256-021-00368-1openalex-snapshot
Chemical language models enable navigation in sparsely populated chemical space
inferred← citeshttps://doi.org/10.1038/s42256-021-00403-1openalex-snapshot
Multi-constraint molecular generation based on conditional transformer, knowledge distillation and reinforcement learning
inferred← citeshttps://doi.org/10.1038/s42256-021-00418-8openalex-snapshot
Geometric deep learning on molecular representations
inferred← citeshttps://doi.org/10.1038/s42256-024-00821-xopenalex-snapshot
Invalid SMILES are beneficial rather than detrimental to chemical language models
showing the first 199 of 362 · page through all 362
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.